ICS 2016 Scientific Podium Short Oral Session S18 - Overactive Bladder and Paediatrics

Speakers
	Scientific Podium Short Oral Session S18
	Thursday 15th September 2016
	11:00 - 12:30
	Hall B5 Capacity: 480
	Lunch provided
D David Castro-Diaz ICS Chair K Kwang Myung Kim ICS Chair S Stephen Shei-Dei Yang ICS Chair
Professional interest
Urology

11:00

#273 Characterizing Real-World Elderly Patients with Overactive Bladder in the United States

Presenter: Kelly H Zou

Ganz M L¹, Liu J¹, Zou K H², Luo X²
1. Evidera, 2. Pfizer
Overactive Bladder, Retrospective Study, Gerontology

11:07

#274 Falls and locomotive syndrome is the major risk factor for overactive bladder

Presenter: Mitsuru Kajiwara

Kajiwara M¹, Nishida K¹, Takemoto K¹, Nakahara M¹, Moriyama H²
1. Hiroshima Prefectural Hospital, Hiroshima, Japan, 2. JA Onomichi General Hospiral, Hiroshima, Japan
Overactive Bladder, Questionnaire, Female

11:15

#275 The utility of Urge perception index (UPI) in diagnosis of severity and therapeutic effect on overactive bladder or bladder hypersensitivity

Presenter: Atsuko Fujihara

Fujihara A¹, Saito Y¹, Honjo H¹, Iwata T¹, Ushijima S¹, Kamoi K¹, Okihara K¹, Ukimura O¹
1. Kyoto prefectural university of medicine
Overactive Bladder, Urgency/Frequency, Voiding Diary

11:22

#276 Population-Based Survey of Overactive Bladder in Japan: A Cross-Sectional Analysis of the Nagahama study

Presenter: Satoshi Funada

Funada S¹, Kawaguchi T², Terada N¹, Negoro H¹, Akamatsu S¹, Kobayashi T¹, Yamasaki T¹, Inoue T¹, Kamba T¹, Yoshimura K³, Matsuda F², Ogawa O¹
1. Kyoto University Hospital, Dept. Of Urology, 2. Kyoto University, Graduate School of Medicine, Center For Genomic Medicine, 3. Shizuoka General Hospital, Dept. Of Urology
Overactive Bladder, Outcomes Research Methods, Male, Female

11:30

#277 Urinary stem cell factor in women with overactive bladder syndrome

Presenter: Yasue Kubota

Kubota Y¹, Hamakawa T¹, Sasaki S¹, Kohri K¹, Yasui T¹
1. Nagoya City University
Female, Pharmacology, Overactive Bladder

11:37

#278 Safety and therapeutic efficacy of mirabegron 25 mg in very old and frail patients with OAB and multiple comorbidities – comparison with younger patients

Presenter: Yu-Khun Lee

Lee Y¹, Wu S¹, Liao C², Kuo H¹
1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan, 2. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
Pharmacology, Detrusor Overactivity, Urgency/Frequency

11:45

#279 Comparative study between different combination of mirabegron (25 or 50 mg) and antimuscarinics in treatment of OAB patients

Presenter: Yuh-Chen Kuo

Kuo Y¹, Jiang Y², Ong H², Kuo H²
1. Department of Urology, Yangming Branch of Taipei City Hospital, Taipei, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Urgency/Frequency, Pharmacology, Clinical Trial

11:52

#280 Efficacy and Safety of Fesoterodine Treatment for Overactive Bladder (OAB) Symptoms in Elderly Women With and Without Hypertension

Presenter: Masaki Yoshida

Yoshida M¹, Hotta S², Hiro S², Yamagami H², Yokoyama O³
1. National Center for Geriatrics and Gerontology, 2. Pfizer Japan, 3. The University of Fukui Faculty of Medical Sciences
Overactive Bladder, Female, Urgency Urinary Incontinence, Urgency/Frequency, Quality of Life (QoL)

12:00

#281 Post-void residual (PVR) volume and urinary retention assessments in a randomized, double-blind, Phase IIIb trial of mirabegron add-on treatment in incontinent overactive bladder (OAB) patients with an inadequate response to 4-week solifenacin monotherapy (BESIDE)

Presenter: Sender Herschorn

Drake M¹, MacDiarmid S², Al-Shukri S³, Barkin J⁴, Fianu-Jonasson A⁵, Grise P⁶, Herschorn S⁴, Huang M⁷, Stölzel M⁷, Hemsted C⁷, Siddiqui E⁷
1. University of Bristol and Bristol Urological Institute, 2. Alliance Urology Specialists, 3. Pavolv 1st State Medical University, 4. University of Toronto, 5. Karolinksa University Hospital, 6. Rouen University Hospital, 7. Astellas
Detrusor Overactivity, Clinical Trial, Incontinence

12:07

#282 DIFFERENCE IN UROFLOWCURVES OF VOIDING ON FIXED TIMES COMPARED TO MICTURITION WHEN FEELING URGE: A PILOT STUDY

Presenter: Alexandra Vermandel

Van der Cruyssen K¹, De Wachter S¹, Meersman C¹, Van Aggelpoel T¹, Vermandel A¹
1. University of Antwerp
Pediatrics, Voiding Dysfunction , Physiotherapy

12:15

#283 Serial ambulatroy uroflowmetry after transurethral ablation of posterior urethral valves – a pilot study-

Presenter: Akihiro Kanematsu

Kanematsu A¹, Hashimoto T¹, Yamamoto S¹
1. Urology, Hyogo College of Medicine
Incontinence, New Devices, Nocturnal Enuresis, Urodynamics Equipment, Pediatrics

12:22

#284 Outcomes of sacral neuromodulation in children with dysfunctional elimination syndrome

Presenter: Reena Kabaria

Kabaria R¹, Fox P¹, Wilson S¹, Klaassen Z¹, Lewis R¹, Neal, Jr D E¹
1. Medical College of Georgia at Augusta University
Neuromodulation, Pediatrics, Voiding Dysfunction

Content Visitors (staff only)

International Continence Society

Overactive Bladder and Paediatrics

Session Schedule

International Continence Society

Overactive Bladder and Paediatrics

Session Schedule

Comments

Chat